Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Pavel

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Neuroendocrinology|April 18, 2012
Translation of molecular pathways into clinical trials of neuroendocrine tumorsMarianne Pavel
Innere Medizin (Heidelberg, Germany)|June 20, 2024
[Gastrointestinal neuroendocrine tumors: update 2024]Harald Lahner, Marianne Pavel
Targeted Oncology|August 14, 2012
Inhibition of mTOR in carcinoid tumorsSimona Grozinsky-Glasberg, Marianne Pavel
Neuroendocrinology|February 13, 2017
ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine TumorsMarianne Pavel, Wouter W de Herder
Seminars in Oncology|February 9, 2013
Systemic therapeutic options for carcinoidMarianne Pavel, Mark Kidd, Irvin Modlin
Archives of Clinical and Medical Case Reports|August 26, 2022
Watch and Wait Strategies in NET Patients: More than ExpectedSebastian Krug, Anja Rinke, Marianne Pavel
Neuroendocrinology|September 7, 2011
From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumorsBertram Wiedenmann, Marianne Pavel, Beata Kos-Kudla
The New England Journal of Medicine|October 16, 2014
Lanreotide in metastatic enteropancreatic neuroendocrine tumorsMartyn E Caplin, Marianne Pavel, Philippe Ruszniewski
Frontiers of Hormone Research|August 26, 2015
The Role of Chemotherapy in Well-Differentiated Gastroenteropancreatic Neuroendocrine TumorsJonathan Strosberg, Jamie Goldman, Frederico Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2022
Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?Thomas A Hope, Marianne Pavel, Emily K Bergsland
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Neuroendocrinology|April 18, 2012
Translation of molecular pathways into clinical trials of neuroendocrine tumorsMarianne Pavel
Innere Medizin (Heidelberg, Germany)|June 20, 2024
[Gastrointestinal neuroendocrine tumors: update 2024]Harald Lahner, Marianne Pavel
Targeted Oncology|August 14, 2012
Inhibition of mTOR in carcinoid tumorsSimona Grozinsky-Glasberg, Marianne Pavel
Neuroendocrinology|February 13, 2017
ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine TumorsMarianne Pavel, Wouter W de Herder
Seminars in Oncology|February 9, 2013
Systemic therapeutic options for carcinoidMarianne Pavel, Mark Kidd, Irvin Modlin
Archives of Clinical and Medical Case Reports|August 26, 2022
Watch and Wait Strategies in NET Patients: More than ExpectedSebastian Krug, Anja Rinke, Marianne Pavel
Neuroendocrinology|September 7, 2011
From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumorsBertram Wiedenmann, Marianne Pavel, Beata Kos-Kudla
The New England Journal of Medicine|October 16, 2014
Lanreotide in metastatic enteropancreatic neuroendocrine tumorsMartyn E Caplin, Marianne Pavel, Philippe Ruszniewski
Frontiers of Hormone Research|August 26, 2015
The Role of Chemotherapy in Well-Differentiated Gastroenteropancreatic Neuroendocrine TumorsJonathan Strosberg, Jamie Goldman, Frederico Costa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2022
Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?Thomas A Hope, Marianne Pavel, Emily K Bergsland
Pageof 14